{"id":"https://openalex.org/W3095861981","doi":"https://doi.org/10.1182/blood-2020-138569","title":"Reduced-Intensity Chemotherapy with Mini-Hyper-CVD Plus Inotuzumab Ozogamicin, with or without Blinatumomab, in Older Adults with Newly Diagnosed Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia: Results from a Phase II Study","display_name":"Reduced-Intensity Chemotherapy with Mini-Hyper-CVD Plus Inotuzumab Ozogamicin, with or without Blinatumomab, in Older Adults with Newly Diagnosed Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia: Results from a Phase II Study","publication_year":2020,"publication_date":"2020-11-04","ids":{"openalex":"https://openalex.org/W3095861981","doi":"https://doi.org/10.1182/blood-2020-138569","mag":"3095861981"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2020-138569","doi":"https://doi.org/10.1182/blood-2020-138569","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2020-138569","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5091492845","display_name":"Nicholas James Short","orcid":"https://orcid.org/0000-0002-2983-2738","observed_orcids":["https://orcid.org/0000-0002-2983-2738"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nicholas J. Short","raw_affiliation_strings":["Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090435894","display_name":"Hagop M. Kantarjian","orcid":"https://orcid.org/0000-0002-1908-3307","observed_orcids":["https://orcid.org/0000-0002-1908-3307"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hagop M. Kantarjian","raw_affiliation_strings":["Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000750846","display_name":"Farhad Ravandi","orcid":"https://orcid.org/0000-0002-7621-377X","observed_orcids":["https://orcid.org/0000-0002-7621-377X"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Farhad Ravandi","raw_affiliation_strings":["Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057822243","display_name":"Xuelin Huang","orcid":"https://orcid.org/0000-0003-1192-9336","observed_orcids":["https://orcid.org/0000-0003-1192-9336"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xuelin Huang","raw_affiliation_strings":["Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021380291","display_name":"Nitin Jain","orcid":"https://orcid.org/0000-0003-0114-8384","observed_orcids":["https://orcid.org/0000-0003-0114-8384"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nitin Jain","raw_affiliation_strings":["Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020340537","display_name":"Tapan Mahendra Kadia","orcid":"https://orcid.org/0000-0002-9892-9832","observed_orcids":["https://orcid.org/0000-0002-9892-9832"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tapan M. Kadia","raw_affiliation_strings":["Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088881526","display_name":"Joseph David Khoury","orcid":"https://orcid.org/0000-0003-2621-3584","observed_orcids":["https://orcid.org/0000-0003-2621-3584"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph D. Khoury","raw_affiliation_strings":["Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028591457","display_name":"Jeffrey L. Jorgensen","orcid":"https://orcid.org/0000-0002-1875-2986","observed_orcids":["https://orcid.org/0000-0002-1875-2986"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey L. Jorgensen","raw_affiliation_strings":["Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089295627","display_name":"Sa A. Wang","orcid":"https://orcid.org/0000-0001-9385-9911","observed_orcids":["https://orcid.org/0000-0001-9385-9911"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sa A Wang","raw_affiliation_strings":["Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070065917","display_name":"Yesid Alvarado","orcid":"https://orcid.org/0000-0002-1652-7937","observed_orcids":["https://orcid.org/0000-0002-1652-7937"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yesid Alvarado","raw_affiliation_strings":["Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058755419","display_name":"Jan A. Burger","orcid":"https://orcid.org/0000-0002-6177-7572","observed_orcids":["https://orcid.org/0000-0002-6177-7572"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jan A. Burger","raw_affiliation_strings":["Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035605515","display_name":"Naval Guastad Daver","orcid":"https://orcid.org/0000-0001-7103-373X","observed_orcids":["https://orcid.org/0000-0001-7103-373X"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Naval Daver","raw_affiliation_strings":["Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055045706","display_name":"Gautam M. Borthakur","orcid":"https://orcid.org/0000-0001-7679-6453","observed_orcids":["https://orcid.org/0000-0001-7679-6453"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gautam Borthakur","raw_affiliation_strings":["Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010786159","display_name":"Courtney Denton Dinardo","orcid":"https://orcid.org/0000-0001-9003-0390","observed_orcids":["https://orcid.org/0000-0001-9003-0390"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Courtney D. DiNardo","raw_affiliation_strings":["Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022647201","display_name":"Marina Y Konopleva","orcid":"https://orcid.org/0000-0002-9347-2212","observed_orcids":["https://orcid.org/0000-0002-9347-2212"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marina Konopleva","raw_affiliation_strings":["Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088307376","display_name":"Naveen Pemmaraju","orcid":"https://orcid.org/0000-0002-1670-6513","observed_orcids":["https://orcid.org/0000-0002-1670-6513"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Naveen Pemmaraju","raw_affiliation_strings":["Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061026876","display_name":"Guillermo Garcia\u2010Manero","orcid":"https://orcid.org/0000-0002-3631-2482","observed_orcids":["https://orcid.org/0000-0002-3631-2482"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Guillermo Garcia-Manero","raw_affiliation_strings":["Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089428686","display_name":"William G. Wierda","orcid":"https://orcid.org/0000-0002-7357-270X","observed_orcids":["https://orcid.org/0000-0002-7357-270X"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William G. Wierda","raw_affiliation_strings":["Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016607292","display_name":"Steven Mitchell Kornblau","orcid":"https://orcid.org/0000-0002-5990-9548","observed_orcids":["https://orcid.org/0000-0002-5990-9548"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Steven M. Kornblau","raw_affiliation_strings":["Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112411374","display_name":"Jovitta Jacob","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jovitta Jacob","raw_affiliation_strings":["Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002849366","display_name":"Meagan Rostykus","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Meagan Rostykus","raw_affiliation_strings":["Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077963154","display_name":"Monica I. Kwari","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Monica Kwari","raw_affiliation_strings":["Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050975340","display_name":"Caitlin R. Rausch","orcid":"https://orcid.org/0000-0002-4166-5717","observed_orcids":["https://orcid.org/0000-0002-4166-5717"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Caitlin R. Rausch","raw_affiliation_strings":["Department of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087551533","display_name":"Christopher R. Loiselle","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher Loiselle","raw_affiliation_strings":["Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058294747","display_name":"Anna Milton","orcid":"https://orcid.org/0000-0002-5883-0934","observed_orcids":["https://orcid.org/0000-0002-5883-0934"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anna Milton","raw_affiliation_strings":["Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Juan Rivera","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Juan Rivera","raw_affiliation_strings":["Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043585566","display_name":"Rebecca E. Garris","orcid":"https://orcid.org/0000-0001-8009-5529","observed_orcids":["https://orcid.org/0000-0001-8009-5529"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rebecca Garris","raw_affiliation_strings":["Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102743501","display_name":"Susan Mary O'Brien","orcid":"https://orcid.org/0000-0003-3386-6540","observed_orcids":["https://orcid.org/0000-0003-3386-6540"]},"institutions":[{"id":"https://openalex.org/I204250578","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771","country_code":"US","type":"education","lineage":["https://openalex.org/I204250578"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Susan M. O'Brien","raw_affiliation_strings":["UCI Cancer Center, Orange, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCI Cancer Center, Orange, CA","institution_ids":["https://openalex.org/I204250578"]}]},{"author_position":"last","author":{"id":null,"display_name":"Elias Jabbour","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elias Jabbour","raw_affiliation_strings":["Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":2.4317,"has_fulltext":false,"cited_by_count":19,"citation_normalized_percentile":{"value":0.90050078,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":98},"biblio":{"volume":"136","issue":"Supplement 1","first_page":"15","last_page":"17"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/philadelphia-chromosome-negative-acute-lymphoblastic-leukemia","display_name":"Philadelphia chromosome-negative acute lymphoblastic leukemia","score":0.9369999766349792},{"id":"https://openalex.org/keywords/b-cell-acute-lymphoblastic-leukemia","display_name":"B-cell acute lymphoblastic leukemia","score":0.8199999928474426},{"id":"https://openalex.org/keywords/older-adults","display_name":"older adults","score":0.8109999895095825},{"id":"https://openalex.org/keywords/reduced-intensity-chemotherapy","display_name":"reduced-intensity chemotherapy","score":0.9179999828338623},{"id":"https://openalex.org/keywords/inotuzumab-ozogamicin","display_name":"inotuzumab ozogamicin","score":0.984000027179718},{"id":"https://openalex.org/keywords/blinatumomab","display_name":"blinatumomab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.7170000076293945},{"id":"https://openalex.org/keywords/hepatic-veno-occlusive-disease","display_name":"veno-occlusive disease","score":0.8510000109672546},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.34299999475479126},{"id":"https://openalex.org/keywords/complete-remission","display_name":"complete remission","score":0.46000000834465027},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.31700000166893005},{"id":"https://openalex.org/keywords/cd20","display_name":"CD20","score":0.328000009059906}],"concepts":[{"id":"https://openalex.org/C2778020697","wikidata":"https://www.wikidata.org/wiki/Q410189","display_name":"Blinatumomab","level":4,"score":0.969184160232544},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6951260566711426},{"id":"https://openalex.org/C2909962599","wikidata":"https://www.wikidata.org/wiki/Q180664","display_name":"Lymphoblastic Leukemia","level":3,"score":0.6632824540138245},{"id":"https://openalex.org/C2778904597","wikidata":"https://www.wikidata.org/wiki/Q1129111","display_name":"Philadelphia chromosome","level":4,"score":0.5419306755065918},{"id":"https://openalex.org/C2778623314","wikidata":"https://www.wikidata.org/wiki/Q412685","display_name":"Gemtuzumab ozogamicin","level":5,"score":0.5289911031723022},{"id":"https://openalex.org/C2781107101","wikidata":"https://www.wikidata.org/wiki/Q180664","display_name":"Acute lymphocytic leukemia","level":4,"score":0.4625709652900696},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4330092966556549},{"id":"https://openalex.org/C2778336483","wikidata":"https://www.wikidata.org/wiki/Q5090632","display_name":"Chemotherapy regimen","level":3,"score":0.4217725396156311},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4001348316669464},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3814288377761841},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.3383110761642456},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.300912082195282},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.13178741931915283},{"id":"https://openalex.org/C138626823","wikidata":"https://www.wikidata.org/wiki/Q916504","display_name":"Chromosomal translocation","level":3,"score":0.09313905239105225},{"id":"https://openalex.org/C176290653","wikidata":"https://www.wikidata.org/wiki/Q21114013","display_name":"CD33","level":4,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C10205521","wikidata":"https://www.wikidata.org/wiki/Q4035578","display_name":"CD34","level":3,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2020-138569","doi":"https://doi.org/10.1182/blood-2020-138569","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2020-138569","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"sustainable_development_goals_aurora":[],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4223461221","https://openalex.org/W3215637673","https://openalex.org/W3096717851","https://openalex.org/W4320710465","https://openalex.org/W1996815863","https://openalex.org/W4283329796","https://openalex.org/W4361195507","https://openalex.org/W3213271278","https://openalex.org/W4367041068","https://openalex.org/W2952296855"],"abstract_inverted_index":{"Background:":[0],"Inotuzumab":[1],"ozogamicin":[2],"(INO)":[3],"and":[4,34,93,101,141,152,204,218,223,245,267,276,309,353,363,396,406,409,415,449,490,506,511,517,646,663,676,689],"blinatumomab":[5,229,249,253],"both":[6],"improve":[7],"overall":[8,658],"survival":[9],"(OS)":[10],"in":[11,26,37,187,194,303,323,389,432,453,476,480,533,539,550,552,561,571,648,679,690],"relapsed":[12],"or":[13,445,484,581,641,765,846,866,883,898,913,933,947,968,982,995,1007,1133,1145,1158,1172,1195,1209,1226,1240,1265,1279,1291,1303,1315,1327],"refractory":[14],"B-cell":[15,46],"acute":[16],"lymphoblastic":[17],"leukemia":[18],"(ALL).":[19],"Use":[20],"of":[21,53,72,84,133,138,146,179,210,220,228,233,243,248,252,258,263,287,316,436,468,478,496,548,565,583,604,626,661,667,682,687,712,763,844,864,881,896,911,931,945,966,980,993,1005,1131,1143,1156,1170,1193,1207,1224,1238,1263,1277,1289,1301,1313,1325],"these":[22],"effective":[23,647],"monoclonal":[24],"antibodies":[25],"the":[27,159,177,183,317,407,502,521,553,624,680,700],"frontline":[28],"setting":[29],"may":[30],"lead":[31],"to":[32,79,123,170,175,191,224,578,673,705],"deep":[33],"durable":[35,674],"remissions":[36,675],"older":[38,554,649],"adults":[39,650],"with":[40,55,240,473,525,587,636,640,651,656],"newly":[41,56,652],"diagnosed":[42,57,653],"Philadelphia":[43],"chromosome":[44],"(Ph)-negative":[45],"ALL.":[47],"Methods:":[48],"Patients":[49],"(pts)":[50],"\u226560":[51],"years":[52,330,536,542,564,574,686,711],"age":[54,327,684,688],"Ph-negative":[58,654],"pre-B-cell":[59],"ALL,":[60,655],"including":[61],"pts":[62,164,282,294,301,320,335,359,368,391,398,420,457,481,534,540,555,562,572,683,709],"who":[63,421,482],"had":[64,355,599],"received":[65,98,165,364],"no":[66,107,403,474],"more":[67],"than":[68],"1":[69,140,394,461],"prior":[70],"cycle":[71,139,198,211,251,395],"chemotherapy,":[73],"were":[74,77,156,302,337,341,347,361,402,413,509,520,575],"eligible.":[75],"Pts":[76,97,586],"required":[78],"have":[80,283,446],"a":[81,131,493,600,627],"performance":[82],"status":[83],"\u22643,":[85],"total":[86],"bilirubin":[87],"\u22641.5":[88],"mg/dl,":[89],"AST/ALT":[90],"\u22643x":[91],"ULN":[92],"creatinine":[94],"\u22642":[95],"mg/dl.":[96],"mini-hyper-CVD":[99],"(cyclophosphamide":[100],"dexamethasone":[102],"at":[103,110,115,130,307],"50%":[104],"dose":[105,112,132,262],"reduction,":[106,113],"anthracycline,":[108],"methotrexate":[109],"75%":[111],"cytarabine":[114],"0.5":[116],"g/m2":[117],"x":[118],"4":[119,161,226,231,246],"doses)":[120],"for":[121,158,168,291,297,311,343,370,608,708],"up":[122,169],"8":[124,209,219],"cycles.":[125,162],"INO":[126,193,264,489],"was":[127,185,273,328,387,470,531],"initially":[128],"given":[129,157,265],"1.3-1.8mg/m2":[134],"on":[135,143,201,207,215,443,759,840,860,877,892,907,927,941,962,976,989,1001,1127,1139,1152,1166,1189,1203,1220,1234,1259,1273,1285,1297,1309,1321],"day":[136,144,202,208,216],"3":[137,145,171,256,427],"0.8-1.3mg/m2":[142],"cycles":[147,221,227,232,242,247,257],"2-4.":[148],"Rituximab":[149],"(if":[150],"CD20+)":[151],"prophylactic":[153],"IT":[154],"chemotherapy":[155,635,707],"first":[160,433],"Responding":[163],"POMP":[166,244],"maintenance":[167,239],"years.":[172,339],"In":[173],"order":[174],"decrease":[176,697],"risk":[178,519],"veno-occlusive":[180],"disease":[181],"(VOD),":[182],"protocol":[184,701],"amended":[186,704],"3/2017":[188],"(pts":[189],"50+)":[190],"give":[192],"fractionated":[195,488],"doses":[196],"each":[197],"(0.6":[199],"mg/m2":[200,206,214,275],"2":[203,217],"0.3":[205,213],"1;":[212],"2-4)":[222],"administer":[225],"following":[230],"hyper-CVD":[234,637],"plus":[235,638],"INO,":[236,639],"followed":[237],"by":[238,350,384,545,620],"12":[241],"(1":[250,435],"after":[254,268,393,462],"every":[255],"POMP).":[259],"The":[260,466,527],"cumulative":[261],"before":[266],"this":[269],"most":[270],"recent":[271],"amendment":[272],"4.3":[274],"2.7":[277],"mg/m2,":[278],"respectively.":[279,417],"Results:":[280],"73":[281],"been":[284,703],"treated,":[285],"70":[286,318],"whom":[288,437],"are":[289,321],"evaluable":[290,319,369],"efficacy":[292],"(3":[293],"too":[295],"early":[296,404],"response":[298,659],"assessment).":[299],"6":[300,456],"complete":[304],"remission":[305,434,505,551,569],"(CR)":[306],"enrollment":[308],"unevaluable":[310],"morphological":[312],"response.":[313],"Pt":[314],"characteristics":[315],"summarized":[322],"Table":[324],"1.":[325],"Median":[326],"68":[329],"(range,":[331,499],"60-81":[332],"years);":[333],"29":[334],"(41%)":[336],"\u226570":[338,541,573,710],"41%":[340],"positive":[342,349],"TP53":[344,628],"mutation,":[345],"18%":[346],"CRLF2":[348,618],"flow":[351,385,621],"cytometry,":[352],"27%":[354],"adverse-risk":[356],"karyotype.":[357],"38/64":[358],"(59%)":[360],"CD20+":[362],"rituximab.":[365],"Among":[366,418],"64":[367],"morphologic":[371],"response,":[372],"63":[373],"(98%)":[374],"responded":[375],"(CR,":[376],"n=56;":[377],"CRp,":[378],"n=6;":[379],"CRi,":[380],"n=1).":[381],"MRD":[382],"negativity":[383],"cytometry":[386,622],"achieved":[388,422],"53/66":[390],"(80%)":[392],"65/68":[397],"(96%)":[399],"overall.":[400],"There":[401],"deaths,":[405],"30-day":[408],"60-day":[410],"mortality":[411],"rates":[412,508,547],"0%":[414],"3%,":[416],"69":[419],"remission,":[423],"9":[424],"(13%)":[425],"relapsed,":[426],"(4%)":[428],"underwent":[429],"allogeneic":[430,464],"SCT":[431],"subsequently":[438],"relapsed),":[439],"35":[440],"(51%)":[441],"remain":[442],"treatment":[444],"completed":[447],"therapy,":[448],"21":[450],"(32%)":[451],"died":[452],"CR/CRp.":[454],"Notably,":[455],"(9%)":[458,472],"developed":[459],"VOD,":[460],"subsequent":[463],"SCT.":[465],"rate":[467,477,530,603,660,666],"VOD":[469,479],"6/70":[471],"difference":[475],"did":[483,485],"not":[486],"receive":[487],"blinatumomab.":[491],"With":[492],"median":[494],"follow-up":[495],"45":[497],"months":[498],"2-98":[500],"months),":[501],"4-year":[503,528,601,664],"continuous":[504],"OS":[507,529,602,665],"78%":[510],"50%,":[512],"respectively":[513],"(Figure":[514,614],"1A).":[515],"Age":[516],"cytogenetic":[518,589,612,694],"primary":[522],"factors":[523],"associated":[524],"OS.":[526,632],"61%":[532],"60-69":[535,563,685],"vs.":[537,558,606],"34%":[538],"(P=0.06),":[543],"driven":[544],"higher":[546],"death":[549],"(13/29":[556],"[45%]":[557],"8/41":[559],"[20%]":[560],"age;":[566],"P=0.03).":[567],"These":[568],"deaths":[570],"primarily":[576],"due":[577],"infection":[579],"(n=7)":[580],"development":[582],"MDS/AML":[584],"(n=3).":[585],"high-risk":[588,611],"features":[590,613],"(e.g.":[591],"KMT2A":[592],"rearranged,":[593],"low":[594],"hypodiploidy/near":[595],"triploidy,":[596],"complex":[597],"cytogenetics)":[598],"22%":[605],"57%":[607],"patients":[609],"without":[610,642,692],"1B;":[615],"P=0.009).":[616],"Neither":[617],"positivity":[619],"nor":[623],"presence":[625],"mutation":[629],"significantly":[630],"impacted":[631],"Conclusion:":[633],"Reduced-intensity":[634],"blinatumomab,":[643],"is":[644],"safe":[645],"an":[657,760,841,861,878,893,908,928,942,963,977,990,1002,1106,1128,1140,1153,1167,1190,1204,1221,1235,1260,1274,1286,1298,1310,1322],"98%":[662],"50%.":[668],"This":[669],"novel":[670],"regimen":[671],"leads":[672],"apparent":[677],"cure":[678],"majority":[681],"those":[691],"poor-risk":[693],"features.":[695],"To":[696],"treatment-related":[698],"mortality,":[699],"has":[702],"eliminate":[706],"age.":[713],"Disclosures":[714],"Short:":[715],"Amgen:":[716,771,822,1044,1231,1270],"Honoraria;":[717,730,740,743,746,749,755,794,807,1029],"Takeda":[718],"Oncology:":[719],"Consultancy,":[720,793,796,801,806,810,815,823,828,833,1094,1109,1121,1125,1137,1150,1164,1187,1201,1218,1232,1257,1271,1283,1295,1307,1319,1331],"Honoraria,":[721,732,751,757,772,782,789,797,802,811,816,824,829,834,838,858,875,890,905,925,939,960,974,987,999,1013,1017,1021,1025,1041],"Research":[722,725,733,736,752,769,773,776,779,783,786,790,798,803,812,817,820,825,830,835,851,855,869,872,886,901,916,919,922,936,950,954,957,971,1010,1014,1018,1022,1026,1032,1035,1038,1042,1045,1048,1051,1054,1057,1060,1063,1067,1070,1074,1078,1082,1086,1090,1099,1110,1115,1122,1161,1175,1178,1181,1184,1198,1212,1215,1229,1243,1246,1250,1253,1268],"Funding;":[723,726,734,737,753,770,774,777,780,784,787,799,804,813,818,821,826,831,852,856,870,873,887,902,917,920,923,937,951,955,958,972,1015,1019,1023,1027,1033,1036,1039,1043,1046,1049,1052,1055,1058,1064,1068,1071,1075,1079,1083,1087,1162,1176,1179,1182,1185,1199,1213,1216,1230,1244,1247,1251,1254,1269],"Astellas:":[724,800,1053,1200],"AstraZeneca:":[727,805,924,1103],"Consultancy.":[728],"Kantarjian:Janssen:":[729],"Abbvie:":[731,832,1024],"Immunogen:":[735],"Oxford":[738],"Biomedical:":[739],"Delta":[741],"Fly:":[742],"Adaptive":[744,888],"biotechnologies:":[745],"Aptitute":[747],"Health:":[748],"Daiichi-Sankyo:":[750,1069],"BioAscend:":[754],"Actinium:":[756],"Membership":[758,839,859,876,891,906,926,940,961,975,988,1000,1126,1138,1151,1165,1188,1202,1219,1233,1258,1272,1284,1296,1308,1320],"entity's":[761,842,862,879,894,909,929,943,964,978,991,1003,1129,1141,1154,1168,1191,1205,1222,1236,1261,1275,1287,1299,1311,1323],"Board":[762,843,863,880,895,910,930,944,965,979,992,1004,1130,1142,1155,1169,1192,1206,1223,1237,1262,1276,1288,1300,1312,1324],"Directors":[764,845,865,882,897,912,932,946,967,981,994,1006,1132,1144,1157,1171,1194,1208,1225,1239,1264,1278,1290,1302,1314,1326],"advisory":[766,847,867,884,899,914,934,948,969,983,996,1008,1134,1146,1159,1173,1196,1210,1227,1241,1266,1280,1292,1304,1316,1328],"committees;":[767,848,984,997,1135,1147,1281,1293,1305,1317,1329],"Ascentage:":[768,1037],"Jazz:":[775,1330],"Sanofi:":[778],"Pfizer:":[781,918,1016,1163],"BMS:":[785,827,921,1020],"Novartis:":[788,1028,1306],"Funding.":[791,836,1011,1061,1091,1123],"Ravandi:Celgene:":[792],"Orsenix:":[795],"Jazz":[808,1088],"Pharmaceuticals:":[809,1066,1081,1089,1093],"Xencor:":[814],"Macrogenics:":[819],"Jain:Janssen:":[837],"Fate":[849,1248],"Therapeutics:":[850,854,953,986,1098,1249],"Aprea":[853],"Servier:":[857,1180],"committees,":[868,885,900,915,935,949,970,1009,1160,1174,1197,1211,1228,1242,1267],"Cellectis:":[871],"Verastem:":[874],"Biotechnologies:":[889],"Precision":[903],"Bioscienes:":[904],"Genentech:":[938,1040,1183],"ADC":[952],"Incyte:":[956,1056],"Pharmacyclics:":[959],"BeiGene:":[973],"TG":[985,1097],"AbbVie:":[998,1186],"Kadia:JAZZ:":[1012],"Astra":[1030],"Zeneca:":[1031],"Cyclacel:":[1034],"Cellenkos:":[1047],"Celgene:":[1050,1318],"Pulmotec:":[1059],"Alvarado:FibroGen:":[1062],"Astex":[1065],"Sun":[1072],"Pharma:":[1073,1077],"MEI":[1076],"Tolero":[1080],"BerGenBio":[1084],"ASA:":[1085],"Burger:Janssen":[1092],"Speakers":[1095,1101,1112,1117],"Bureau;":[1096,1102,1113,1118],"Funding,":[1100,1111,1116],"Consultancy;":[1104],"Pharmacyclics,":[1105],"AbbVie":[1107],"company:":[1108],"Beigene:":[1114],"Gilead":[1119],"Sciences:":[1120],"Daver:Trillium:":[1124],"Syndax:":[1136],"Bristol-Myers":[1148],"Squibb:":[1149],"Karyopharm:":[1177],"Novimmune:":[1214],"Gilead:":[1217],"Trovagene:":[1245],"ImmunoGen:":[1252],"Daiichi":[1255],"Sankyo:":[1256],"KITE:":[1282],"Agios:":[1294],"Membe":[1332]},"counts_by_year":[{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":6}],"updated_date":"2026-10-02T10:15:12.560889","created_date":"2025-10-10T00:00:00"}